| Engineering multifunctional capsules through the assembly of metal–phenolic networks J Guo, Y Ping, H Ejima, K Alt, M Meissner, JJ Richardson, Y Yan, K Peter, ... Angewandte Chemie International Edition 53 (22), 5546-5551, 2014 | 870 | 2014 |
| Integrin cytoplasmic domains mediate inside-out signal transduction TE O'Toole, Y Katagiri, RJ Faull, K Peter, R Tamura, V Quaranta, ... The Journal of cell biology 124 (6), 1047-1059, 1994 | 868 | 1994 |
| The emerging threat of (micro) thrombosis in COVID-19 and its therapeutic implications JD McFadyen, H Stevens, K Peter Circulation research 127 (4), 571-587, 2020 | 612 | 2020 |
| Microparticles: major transport vehicles for distinct microRNAs in circulation P Diehl, A Fricke, L Sander, J Stamm, N Bassler, N Htun, M Ziemann, ... Cardiovascular research 93 (4), 633-644, 2012 | 595 | 2012 |
| Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease DM Good, P Zürbig, A Argiles, HW Bauer, G Behrens, JJ Coon, M Dakna, ... Molecular & cellular proteomics 9 (11), 2424-2437, 2010 | 548 | 2010 |
| Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P … K Peter, P Nawroth, C Conradt, T Nordt, T Weiss, M Boehme, A Wunsch, ... Arteriosclerosis, thrombosis, and vascular biology 17 (3), 505-512, 1997 | 412 | 1997 |
| Clinical proteomics: a need to define the field and to begin to set adequate standards H Mischak, R Apweiler, RE Banks, M Conaway, J Coon, A Dominiczak, ... PROTEOMICS–Clinical Applications 1 (2), 148-156, 2007 | 360 | 2007 |
| Recommendations for biomarker identification and qualification in clinical proteomics H Mischak, G Allmaier, R Apweiler, T Attwood, M Baumann, A Benigni, ... Science translational medicine 2 (46), 46ps42-46ps42, 2010 | 326 | 2010 |
| Induction of Fibrinogen Binding and Platelet Aggregation as a Potential Intrinsic Property of Various Glycoprotein IIb/IIIa (IIbβ3) Inhibitors K Peter, M Schwarz, J Ylänne, B Kohler, M Moser, T Nordt, P Salbach, ... Blood, The Journal of the American Society of Hematology 92 (9), 3240-3249, 1998 | 320 | 1998 |
| Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities LA Bienvenu, J Noonan, X Wang, K Peter Cardiovascular research 116 (14), 2197-2206, 2020 | 319 | 2020 |
| New oral anticoagulant drugs in cardiovascular disease I Ahrens, GYH Lip, K Peter Thrombosis and haemostasis 104 (07), 49-60, 2010 | 317 | 2010 |
| Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques SU Eisenhardt, J Habersberger, A Murphy, YC Chen, KJ Woollard, ... Circulation research 105 (2), 128-137, 2009 | 310 | 2009 |
| CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1 A Zirlik, C Maier, N Gerdes, L MacFarlane, J Soosairajah, U Bavendiek, ... Circulation 115 (12), 1571-1580, 2007 | 281 | 2007 |
| Urinary proteomic biomarkers in coronary artery disease LU Zimmerli, E Schiffer, P Zürbig, DM Good, M Kellmann, L Mouls, AR Pitt, ... Molecular & cellular proteomics 7 (2), 290-298, 2008 | 261 | 2008 |
| Current and future antiplatelet therapies: emphasis on preserving haemostasis JD McFadyen, M Schaff, K Peter Nature Reviews Cardiology 15 (3), 181-191, 2018 | 258 | 2018 |
| Obligatory role for B cells in the development of angiotensin II–dependent hypertension CT Chan, CG Sobey, M Lieu, D Ferens, MM Kett, H Diep, HA Kim, ... Hypertension 66 (5), 1023-1033, 2015 | 234 | 2015 |
| Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets M Schwarz, G Meade, P Stoll, J Ylanne, N Bassler, YC Chen, ... Circulation research 99 (1), 25-33, 2006 | 233 | 2006 |
| Dissociation of pentameric to monomeric C-reactive protein localizes and aggravates inflammation: in vivo proof of a powerful proinflammatory mechanism and a new anti … JR Thiele, J Habersberger, D Braig, Y Schmidt, K Goerendt, V Maurer, ... Circulation 130 (1), 35-50, 2014 | 226 | 2014 |
| C-reactive protein: how conformational changes influence inflammatory properties SU Eisenhardt, JR Thiele, H Bannasch, GB Stark, K Peter Cell cycle 8 (23), 3885-3892, 2009 | 211 | 2009 |
| Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension SM Krishnan, YH Ling, BM Huuskes, DM Ferens, N Saini, CT Chan, ... Cardiovascular Research 115 (4), 776-787, 2019 | 210 | 2019 |
